HHS R&D Arm, AstraZeneca Form Antibiotic Development Partnership; Robin Robinson Comments
AstraZeneca and the Department of Health and Human Services have signed a partnership agreement on the development of antibiotics for drug-resistant infections and potential bioterrorism threats. HHS said Wednesday the public-private partnership also includes a cost-sharing deal in which the department’s Biomedical Advanced Research and Development Authority will contribute up to $170 million over a five-year period. “This agreement demonstrates our […] More